Details for Patent: 7,458,374
✉ Email this page to a colleague
Which drugs does patent 7,458,374 protect, and when does it expire?
Patent 7,458,374 protects ADASUVE and is included in one NDA.
This patent has two hundred and six patent family members in twenty-one countries.
Summary for Patent: 7,458,374
| Title: | Method and apparatus for vaporizing a compound |
| Abstract: | Disclosed is a method and device for rapid heating of a coated substance which preferably includes a drug to vaporized for inhalation therapy. A device in accordance with the present invention preferably includes a substrate which has an interior surface surrounding an interior region and an exterior surface upon which the coated substance is to be adhered. Though the substrate is preferably metallic, it does not need to be. A combustible element is placed in the interior region of the rigid substrate and an igniter is connected to the combustible element. The igniter is for initiating oxidation of the combustible element. Preferably, the coated substance is vaporized inside of a housing to allow the vaporized drug to aerosolize and be inhaled by a user. |
| Inventor(s): | Hale; Ron L. (Woodside, CA), Song; Soonho (Hillsborough, CA), Quintana; Reynaldo J. (Redwood City, CA), Zaffaroni; Alejandro C. (Atherton, CA), Rabinowitz; Joshua D. (Princeton, NJ) |
| Assignee: | Alexza Pharmaceuticals, Inc. (Mountain View, CA) |
| Application Number: | 10/146,086 |
|
Patent Claim Types: see list of patent claims | Composition; Device; Use; |
Drugs Protected by US Patent 7,458,374
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alexza Pharms | ADASUVE | loxapine | POWDER;INHALATION | 022549-001 | Dec 21, 2012 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,458,374
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1389098 | ⤷ Sign Up | C300609 | Netherlands | ⤷ Sign Up |
| European Patent Office | 1389098 | ⤷ Sign Up | CA 2013 00046 | Denmark | ⤷ Sign Up |
| European Patent Office | 1389098 | ⤷ Sign Up | CR 2013 00046 | Denmark | ⤷ Sign Up |
| European Patent Office | 1389098 | ⤷ Sign Up | 1390040-2 | Sweden | ⤷ Sign Up |
| European Patent Office | 1389098 | ⤷ Sign Up | 300609 | Netherlands | ⤷ Sign Up |
| European Patent Office | 1389098 | ⤷ Sign Up | 473 | Finland | ⤷ Sign Up |
| European Patent Office | 1389098 | ⤷ Sign Up | 2013C/054 | Belgium | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
